MyFair Cream: A Triple-Combination Therapy for Hyperpigmentation

n 
n

This WHO GMP-certified topical formulation targets hyperpigmentation (e.g., melasma, dark patches) through the synergistic action of three pharmacologically active compounds:

n

n
• Hydroquinone (2% w/w): A depigmenting agent that interferes with melanin synthesis.

n

• Mometasone (0.1% w/w): A potent topical corticosteroid that provides anti-inflammatory, anti-pruritic, and vasoconstrictive properties, mitigating associated redness and inflammation.

n

• Tretinoin (0.025% w/w): A retinoid that promotes epidermal turnover, facilitating the removal of pigmented keratinocytes.

n

nUsage is indicated for individuals presenting with uneven skin tone, dark spots, or melasma who are seeking dermatological treatment for complexion equalization.